Patients Taking Ozempic Are Up to 70 Percent Less Likely to Develop Alzheimer’s, Research Finds

Quick Summary:

The active ingredient in Ozempic and Wegovy has once again proven to have health effects outside of weight loss in a huge analysis linking it to lowered Alzheimer's disease risk.

Their goal: to see how well they fared over time, and to see if there were links to be drawn between their diabetes medications and their cognitive health outcomes.

From potentially preventing Alzheimer's to lowering the urge to drink and smoke, these drugs are proving time and again to be massive pharmaceutical game-changers — although the exact mechanism of why, as always, remains strikingly elusive.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Noor Al-Sibai

Category: Technology

Markets: United States

Topics: Rx/Medicines Alzheimer's Neoscope Wegovy Semaglutide Ozempic

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-10-26 @ 13:30:29 (2 days ago)

News Timezone: GMT +8:00

News Source URL: futurism.com

Language: English

Article Length: 447 words

Reading Time: 3 minutes read

Sentences: 15 lines

Sentence Length: 30 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Futurism

News ID: 23251668

View Article Analysis

About Futurism

Main Topics: Technology

Official Website: futurism.com

Year Established: 1997

Headquarters: United States

News Last Updated: 2 days ago

Coverage Areas: United States

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #68

Publisher Details

Frequently Asked Questions